Opioïdes et douleur chronique non cancéreuse : enjeux cliniques

American Academy of Pain Medicine and the American Pain Society. (1997). « The use of opioids for the treatment of chronic pain. A consensus statement ». The Clinical Journal of Pain. Vol. 13, p. 6-8.

American Academy of Pain Medicine, American Pain Society and American Society of Addiction Medicine (2001). « Definitions Related to the Use of Opioids for the Treatment of Pain ». Page consultée en ligne sur le site www.painmed.org/pdf/definition.pdf.

Ballantyne, J. C. et Mao, J. (2003). « Opioid Therapy for Chronic Pain ». The New England Journal of Medicine. Vol. 349, p. 1943-1953.

Bannwarth, B., Bertin, P. et Queneau, P. (2001). « Les opioïdes forts dans les douleurs chroniques non cancéreuses ». La Presse Médicale. Vol. 30, n^o 19, p. 947-950.

Bloodworth, D. (2005). « Issues in Opioid Management ». The American Journal of Physical Medicine and Rehabilitation. Vol. 84, n^o 3, p. S42-S55.

Burton, A., Balagué, F., Cardon, G., Eriksen, R., Henrotin, Y., Lahad, A., Leclerc, A., Müller, G. et Van der beek, A. (2006). « European guidelines for prevention in low back pain (chapter 2) ». European Spine Journal. Vol. 15, n^o 2, p. 136-168.

Chou, R., Clark, E. et Helfand, M. (2003). « Comparative Efficacy and Safety of Long-Acting Oral Opioids for Chronic Non-Cancer Pain: A Systematic Review ». Journal of Pain and Symptom Management. Vol. 26, p. 1026-1048.

De Craen, A.J., Lampe-Schoenmaeckers, A.J., Kraal, J.W., Tijssen, J.G. et Kleijnen, J. (2001). « Impact of experimentally-induced expectancy on the analgesic efficacy of tramadol in chronic pain patients: a 2 x 2 factorial, randomized, placebo-controlled, double-blind trial ». Journal of Pain and Symptom Management. Vol. 21, n^o 3, p. 210-217.

Dersh, J., Polatin, P. et Gatchel, R. J. (2002). « Chronic Pain and Psychopathology: Research Findings and Theoretical Considerations ». Psychosomatic Medicine. Vol. 64, p. 773-786.

Dersh, J., Gatchel, R. J., Mayer, T., Polatin, P. et Temple, O. R. (2006). « Prevalence of Psychiatric Disorders in Patients With Chronic Disabling Occupational Spinal Disorders ». Spine. Vol. 31, n^o 10, p. 1156-1162.

Eisenberg, E., McNical, E. D. et Carr, D. B. (2005). « Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin ». The Journal of the American Medical Association. Vol. 293, n^o 24, p. 3043-3052.

Eriksen, J., Sjogren, P., Bruera, E., Ekholm, O. et Rasmussen, N. K. (2006). « Critical issues on opioids in chronic non-cancer pain: An epidemiological study ». Pain. Vol. 125, p.172-179.

Farrar, J., Young, J. J., LaMoreaux, L., et coll. (2001). « Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale ». Pain. Vol. 94, p. 149-158.

Fischer, B., Rehm, J., Patra, J., et Firestone Cruz, M. (2007). « Changes in illicit opioid use across Canada ». The Canadian Medical Association Journal. Vol. 175, n^o 11, p. 1385-1387.

Foley, K.M. (2007). « History of Malignant Pain Treatment with Opioids ». NIH Conference: Pain, Opioids, and Addiction: an Urgent Problem for Doctors and Patients.

Furlan, A. D., Sandoval, J. A., Mailis-Gagnon, A. et Tunks, E. (2006). « Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects », The Canadian Medical Association Journal. Vol. 174, n^o 11, p. 1589-1594.

Gatchel, R. J., Polatin, P. B. et Mayer, T. G. (1995). « The Dominant Role of Psychosocial Risk Factors in the Development of Chronic Low Back Pain Disability ». Spine. Vol. 20, n^o 24, p. 2702-2709.

Gatchel, R. et Turk, D. (1999). Psychosocial Factors in Pain. New York : Gilford Press

Gureje, O., Simon, G. E. et Von Korff, M. (2001). « A cross-national study of the course of persistent pain in primary care ». Pain. Vol. 92, p. 195-200.

Jadad, A. et Browman, J.P. (1995). « The WHO analgesic ladder for cancer pain. Stepping up the quality of its evaluation ». The Journal of the American Medical Association. Vol. 274, p. 1870-1873.

Jensen, M. (2003). « The validity and reliability of pain measures in adults with cancer ». The Journal of Pain. Vol. 4, p. 2-21.

Jovey, R. D., Ennis, J., Gardner-Nix, J., Goldman, B., Hays, H., Lynch, M. et Moulin, D. (2003). « L’utilisation d’analgésiques opioïdes pour le traitement de la douleur chronique non cancéreuse - Déclaration de consensus et lignes directrices 2002 de la Société canadienne pour le traitement de la douleur ». Pain Research and Management. Vol. 8, Suppl. A, p. 15A-28A.

Kahan, M., Srivastava, A., Wilson, L., Mailis-Gagnon, A. et Midmer, D. (2006). « Opioids for managing chronic non-malignant pain: Safe and effective prescribing ». The Canadian Family Physician. Vol. 52, n^o 9, p. 1091-1096.

Kalso, E., Edwards, J. E., Moore, R. A. et McQuay, H. J. (2004). « Opioids in chronic non-cancer pain: systematic review of efficacy and safety ». Pain. Vol. 112, p. 372-380.

Katz, N., Adams, E., Benneyan, J., et coll. (2007). « Foundations of opioid risk management ». The Clinical Journal of Pain. Vol. 23, p. 103-118.

Katz, N. (2007a). « Safe and Effective Opioids Prescribing in the Internet Age ». NIH Conference: Pain, Opioids, and Addiction: an Urgent Problem for Doctors and Patients.

Katz, N. (2007b). « Opioids: After Thousands of years, Still Getting to Know You ». The Clinical Journal of Pain. Vol. 23, p. 303-306.

Linton, S. J. (2000). « A Review of Psychological Risk Factors in Back and Neck Pain ». Spine. Vol. 25, n^o 9, p. 1148-1156.

Main, C. J. et Spanswick, C. C. (2000). Pain Management: An Interdisciplinary Approach. London : Churchill Livingstone.

Mao, J. (2002). « Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy ». Pain. Vol.100, p. 213-217.

Martell, B. A., O’Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R. et Fiellin, D. A. (2007). « Systematic Review: Opioid Treatment for Chronic Back pain: Prevalence, Efficacy, and Association with Addiction ». Annals of Internal Medicine. Vol. 146, n^o 2, p. 116-127.

Melzack, R. (1990). « The Tragedy of Needless Pain ». Scientific American. Vol. 262, n^o 2, p. 27-33.

Moore, R. A. et McQuay, H. J. (2005). « Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomized trails of oral opioids ». Arthritis Research and Therapy. Vol. 7, p. R1046-R1051.

Morley-Forster, P. K., Clark, A. J., Speechley, M. et Moulin, D. E. (2003). « Attitudes toward opioid use for chronic pain: A Canadian physician survey ». Pain Research and Management. Vol. 8, n^o 4, p. 189-194.

Musto, D. F. (2007). « Opioid Addiction in the United States: from opium to the Internet ». NIH Conference: Pain, Opioids, and Addiction: an Urgent Problem for Doctors and Patients.

Nicholson, B. (2003). « Responsible Prescribing of Opioids for the Management of Chronic Pain ». Drugs. Vol. 63, n^o 1, p. 17-32.

Passik, S., Kirsh, K., Whitcomb, L., Portenoy, R., Katz, N., Kleinman, L., Dodd, S. et Schein, J. (2004). « A New Tool to Assess and Document Pain Outcomes in Chronic Pain Patients Receiving Opioid Therapy ». Clinical Therapeutics. Vol. 26, n^o 4, p. 552-561.

Passik, S., Kirsh, K., Whitcomb, L., Schein, J., Kaplan, M., Dodd, S., Kleinman, L., Katz, N. et Portenoy, R. (2005). « Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the pain assessment and documentation tool ». Journal of Opioid Management. Vol. 1, n^o 5, p. 257-266.

Passik, S. (2007). « Aberrant Drug-Taking Behaviors During Pain Management - What Do We Know? ». NIH Conference: Pain, Opioids, and Addiction: an Urgent Problem for Doctors and Patients.

Rajagopal, A., Vassilopoulou-Sellin, R., Palmer, J., Kaur, G. et Bruera, E. (2004). « Symptomatic hypogonadism in male survivors of cancer with chronic exposure to morphine ». Cancer. Vol. 100, p. 851-858.

Rohsenow, D., Colby, S., Martin, R. et Monti, P. (2005). « Nicotine and other substance interaction expectancies questionnaire: Relationship of expectancies to substance use ». Addictive Behaviors. Vol. 30, n^o 4, p. 629-641.

Savage, S. (1996). « Long-term Opioid Therapy: Assessment of Consequences and Risks ». Journal of Pain and Symptom Management. Vol. 11, p. 274-286.

Schofferman, J. (1993). « Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin ». Journal of Pain and Symptom Management. Vol. 11, p. 279-288.

Sees, K. et Clark, H. (1993). « Opioid use in the treatment of chronic pain: assessment of addiction ». Journal of Pain and Symptom Management. Vol. 8, p. 257-264.

Sjogren, P., Thomsen, A. B. et Olsen, A. K. (2000). « Impaired Neuropsychological Performance in Chronic Nonmalignant Pain Patients Receiving Long-Term Oral Opioid Therapy ». Journal of Pain and Symptom Management. Vol. 19, n^o 2, p. 100-108.

Substance Abuse and Mental Health Services Administration. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings. NSDUH Series H-30, DHHS Publication No.SMA 06-4194. Rockville, MD : Office of Applied Studies.

Sullivan, M. (2007). « Epidemiology of Chronic Noncancer Pain and Opioid Treatment ». NIH Conference: Pain, Opioids, and Addiction: an Urgent Problem for Doctors and Patients.

Vallejo, R., de Leon Casasola, O. et Benyamin, R. (2004). « Opioid Therapy and immunosuppression. A review ». American Journal of Therapeutics. Vol. 11, p. 354-365.

Waddell, G. (2000). The Back Pain Revolution. Londres : Churchill Livingstone.

Waddell, G. et Burton, A. K. (2001). « Occupational health guidelines for the management of low back pain work: evidence review ». Occupational Medicine. Vol. 51, n^o 2, p. 124-135.